Skip to main content
Fig. 3 | BMC Complementary Medicine and Therapies

Fig. 3

From: Afzelin induces immunogenic cell death against lung cancer by targeting NQO2

Fig. 3

NQO2 is identified as a potential target of Afzelin in lung cancer cells. A The target gene of Afzelin was predicted using SwissTargetPrediction. B Molecular docking between Afzelin and NQO2 was performed using MOE software. C The distance between Afzelin and the predicted interacting amino acids is shown. D The Tm for NQO2 was determined using DSC. E The NQO2 protein expression in A549 and H1299 cells is shown

Back to article page